Podcast appearances and mentions of Lee Townsend

Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live! Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com/jayvay

Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live! Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com/jayvay

Why does extreme fear occur during abduction events? We'll get in to that about halfway through the episode. What else is this livestream from yesteryear about? A lot. Give a listen. _________________ Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live! Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com/jayvay

Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live! Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com/jayvay

If we don't know what we are then can self-actualized beings actually speak with us at all? Or would it be like speaking to severely mentally ill people who believe they are sane? Here we go! Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live!   Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com/jayvay

This episode we talk about superfluous UFO and ghost hunting shows, UFO hoaxes, the Discovery Channel asking Jeremy to audition for a new UFO show, and waaaaay more. Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live! Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com/jayvay

Mark Lee Townsend returns for a proper interview. Whether you know him from Steve Taylor, DC Talk, or Relient K, Mark's impact can't be overstated either on the stage or in the studio. We attempt to cover as much of his remarkable career as possible in an acceptable podcast runtime along with what he has coming in 2025.If you like what you hear, please rate, review, subscribe, and follow!Connect with us here:Email: contact@churchjamsnow.comSite: https://www.churchjamsnow.com/IG: @churchjamsnowTwitter: @churchjamsnowFB: https://www.facebook.com/churchjamsnowpodcastPatreon: https://www.patreon.com/churchjamsnowpodcast

Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live!   Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com/jayvay

Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live!   Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com.jayvay

Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live!   Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com.jayvay

An adorably nervous John Randall calls in about John Mack and the Zimbabwe UFO landing. Later, the Jeff & The Jer talk about drone hoaxes, falling out with people in ufology, and more! *** Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live! Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com.jayvay

Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live!   Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com.jayvay

Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live! Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com.jayvay

Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live!   Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com.jayvay

Jer talks about having the sea in him. Jeff talks about his Shroudman encounters. Somehow, Lee Townsend never calls a psychiatrist. Please help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com.jayvay

Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live! Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com.jayvay

Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live! Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com.jayvay

Sometimes, when you're perceived to have made it as a podcast, jealous folks and sociopaths from smaller/newer shows attack you to make a name for themselves. Eventually, you have to speak up. In this episode, The Jeff & The Jer speak up and take out the trash. Then the trash calls in to try to gaslight us. Fun ensues.  ____________ Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live!   Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com.jayvay

Josh, known as ''jayr'' on the message board, joins us to discuss a post he made about last week's ''Echoes In A Yawning Chasm'' episode that gave Jer some new insights into his nothingness/everythingness identity experience. This is another mind-bending conversation that will have you thinking in perhaps completely new ways. But first, Lee Townsend joins Jeff & Jer to investigate famed channeled entities ''Ramtha'' and ''Seth'' and talk about what makes these entity claims different from Shroud Man and even Jer's unconscious movements, which could easily be mistaken for channeling. (originally aired: 12.01.2011)

Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live! Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com.jayvay

Call-in guests galore on this episode! *** Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live!   Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com.jayvay

Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com.jayvay Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live!

Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live! Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com.jayvay

Because the Paratopia podcast just wasn't enough, Paratopia Live was born. Here Jeff Ritzmann, Jeremy Vaeni, and the official unofficial third host, Lee Townsend, talk about their high strangeness experiences and take calls live! Help keep Our Undoing Radio going. Donate whatever small amount you can today at: www.ko-fi.com.jayvay

It's Time to Rock, OK? Today is the 17th anniversary of Polarity by The Wedding, and we're going track by track through the record with Kevin Kiehn, Cody Driggers, and Mark Lee Townsend. We also discuss The Wedding being courted by Capitol Records along with uncovering a secret pregap track. If you're into podcasts with great behind the scenes stories, This One Is For You. Be sure to catch Part 1 of our conversation if you haven't already.If you like what you hear, please rate, review, subscribe, and follow!Connect with us here:Email: contact@churchjamsnow.comSite: https://www.churchjamsnow.com/IG: @churchjamsnowTwitter: @churchjamsnowFB: https://www.facebook.com/churchjamsnowpodcastPatreon: https://www.patreon.com/churchjamsnowpodcast

Dearly beloved, we are gathered here today to celebrate the 17th anniversary of Polarity by The Wedding. Among those gathered are Kevin Kiehn, Cody, Driggers, and Mark Lee Townsend to cover the record with us. We're splitting this episode into two parts because there's too much great conversation for just one episode. On Part 1 you'll hear some backstory where the band was going into recording Polarity. Lookout for Part 2 where we go track-by-track through the record.If you like what you hear, please rate, review, subscribe, and follow!Connect with us here:Email: contact@churchjamsnow.comSite: https://www.churchjamsnow.com/IG: @churchjamsnowTwitter: @churchjamsnowFB: https://www.facebook.com/churchjamsnowpodcastPatreon: https://www.patreon.com/churchjamsnowpodcast

Deux duos se succèdent dans la #SessionLive avec l'harmoniciste breton de La Réunion Olivier Ker Ourio et le guitariste belge Quentin Dujardin. Puis, le Dj producteur français Praktika avec la griotte burkinabé Dafra Keïta. Nos 1ers invités Quentin Dujardin & Olivier Ker Ourio pour la sortie de l'album Serendipity.Le mot « Sérendipité » est entré dans la langue française très récemment. Sa définition au sens large est le don de faire par hasard des découvertes fructueuses. Une forme de compréhension des choses obtenue par ce hasard lui-même.Olivier Ker Ourio et Quentin Dujardin se rencontrent ainsi en 2016 lors d'un studio en compagnie de Richard Bona, Manu Katché et Ivan Paduart. Depuis cet heureux croisement, le temps a fait son œuvre autour de leurs approches musicales respectives : jazz pour l'harmoniciste, crossover pour le guitariste. C'est avec la reprise étonnante du fameux standard de jazz de Charles Mingus, Goodbye Pork Pie Hat qu'ils ouvrent ce disque en grande pompe. Olivier Ker Ourio n'est jamais loin de son pays natal, La Réunion et de ses réminiscences rocailleuses dans le blues qu'elle porte ; Quentin Dujardin quant à lui, nous transporte avec fraîcheur sur ce groove quasi malien survolé de guitares slides. À leur grand étonnement, une seule journée de studio s'avèrera nécessaire pour graver l'intensité de ce moment posé entre douceur (Eva) et tempo lent (Serendipity). Le travail d'orfèvre de Rémi Bourcereau, ingénieur du son révèle à merveille cette diversité du dialogue qui oscille entre flamenco (Song for Paco), classique (Ave Maria) ou encore blues (Blues for M&N). Par ailleurs, leur imaginaire commun autour des îles n'est jamais loin, il suffit pour s'en convaincre d'écouter Madagascar. Notons aussi ce clin d'œil à Toots Thielemans dans cette nouvelle version du titre En t'attendant que le guitariste avait enregistré à ses côtés en 2010 pour son album intitulé Impressionniste. Olivier Ker Ourio nous en livre une version très personnelle et magnifiquement inspirée. Pour conclure cette envolée, David Linx est l'invité de choix pour un moment suspendu autour de la chanson Shy Away.À propos de Olivier Ker Ourio Salué par les critiques comme un des dignes successeurs de Toots Thielemans, Olivier Ker Ourio est non seulement un soliste très demandé (Alexandre Desplat, Sylvain Luc, Marcel Azzola, Michel Legrand, Didier Lockwood, Danyel Waro...), mais également un brillant compositeur et leader inspiré. Dans ses 11 albums enregistrés à ce jour, ses compositions dévoilent un monde poétique habité de mélodies lyriques, d'harmonies inventives et de rythmes inhabituels. Le monde d' OKO a le souffle de l'âme.À propos de Quentin DujardinCompositeur, guitariste & producteur, Quentin Dujardin crée un univers unique autour de ses guitares nylons. Sa ligne de conduite reste attachée de façon immuable au son et à l'émotion. Le guitariste a notamment collaboré internationalement live ou studio avec Toots Thielemans, Lee Townsend, Manu Katché, Bijan Chemirani, Nicolas Fiszman, Mahsa Vahdat, Richard Bona, Bert Joris, Doron David Sherwin, Didier Laloy et beaucoup d'autres. Il est également ambassadeur pour la Fondation Yehudi Menuhin.Titres interprétés au grand studio : Madagascar Live RFI voirShy Away (Feat. David Linx), extrait de l'albumBlues for M&N, Live RFILine Up : Olivier Ker Ourio, harmonica, Quentin Dujardin, guitareSon : Benoît Letirant & Mathias Taylor (+mixage)► Album Serendipity (Agua Music/ Dist. Inouïe 2024)Voir le clip Song For PacoVoir le clip En T'attendantPuis nous recevons la griotte Dafra Keita et le man machine Praktika pour la sortie de l'album Balani Factory. Le backpacker DJ et producteur français Jérôme Fouqueray aka Praktika a repris la route de l'Afrique de l'Ouest pour son 2e album « Balani Factory », disponible aujourd'hui sur le label Blanc Manioc. Comme fil rouge de ce nouvel album, l'artiste a choisi un instrument qui a traversé les siècles : le balafon. Après des recherches autour de cet instrument ancestral, Praktika a entrepris l'écriture de ce 2e album en s'entourant d'icône de la scène afro électronique comme le grand balafoniste malien Lansiné Kouyaté, et Sly A 10, ancien batteur de Tiken Jah Fakoly et grand percussionniste de Côte d'Ivoire.Au cours de ses recherches, Praktika découvre l'existence de Zélé de Papara, chanteuse ivoirienne des années 90 méconnue du grand public, dont la voix et l'histoire singulière éveillent sa curiosité. Il propose alors à la chanteuse Jahelle ainsi qu'à la rare griotte burkinabé Dafra Keita de poser chacune leur voix sur le morceau en hommage à la chanteuse Zélé de Papara, la cantatrice sénoufo.Titres interprétés au grand studio : Dafra (Feat. Dafra Keita) Live RFIBalany Factory, extrait de l'albumZélé (Feat. Jahelle) Live RFILine Up : Dafra Keita, chanteuse, balafon et chant, Praktika, machinesSon : Jérémie Besset, Mathias Taylor (+mixage)► Album Balani Factory (Blanc Manioc 2024) - Voir le clip Dr BalafonConcerts 27 avril au 4 mai 2024 – Djéguélé Festival (festival du balafon), Bondoukou le 27 avril et Boundiali le 3 mai (Côte d'Ivoire).

Deux duos se succèdent dans la #SessionLive avec l'harmoniciste breton de La Réunion Olivier Ker Ourio et le guitariste belge Quentin Dujardin. Puis, le Dj producteur français Praktika avec la griotte burkinabé Dafra Keïta. Nos 1ers invités Quentin Dujardin & Olivier Ker Ourio pour la sortie de l'album Serendipity.Le mot « Sérendipité » est entré dans la langue française très récemment. Sa définition au sens large est le don de faire par hasard des découvertes fructueuses. Une forme de compréhension des choses obtenue par ce hasard lui-même.Olivier Ker Ourio et Quentin Dujardin se rencontrent ainsi en 2016 lors d'un studio en compagnie de Richard Bona, Manu Katché et Ivan Paduart. Depuis cet heureux croisement, le temps a fait son œuvre autour de leurs approches musicales respectives : jazz pour l'harmoniciste, crossover pour le guitariste. C'est avec la reprise étonnante du fameux standard de jazz de Charles Mingus, Goodbye Pork Pie Hat qu'ils ouvrent ce disque en grande pompe. Olivier Ker Ourio n'est jamais loin de son pays natal, La Réunion et de ses réminiscences rocailleuses dans le blues qu'elle porte ; Quentin Dujardin quant à lui, nous transporte avec fraîcheur sur ce groove quasi malien survolé de guitares slides. À leur grand étonnement, une seule journée de studio s'avèrera nécessaire pour graver l'intensité de ce moment posé entre douceur (Eva) et tempo lent (Serendipity). Le travail d'orfèvre de Rémi Bourcereau, ingénieur du son révèle à merveille cette diversité du dialogue qui oscille entre flamenco (Song for Paco), classique (Ave Maria) ou encore blues (Blues for M&N). Par ailleurs, leur imaginaire commun autour des îles n'est jamais loin, il suffit pour s'en convaincre d'écouter Madagascar. Notons aussi ce clin d'œil à Toots Thielemans dans cette nouvelle version du titre En t'attendant que le guitariste avait enregistré à ses côtés en 2010 pour son album intitulé Impressionniste. Olivier Ker Ourio nous en livre une version très personnelle et magnifiquement inspirée. Pour conclure cette envolée, David Linx est l'invité de choix pour un moment suspendu autour de la chanson Shy Away.À propos de Olivier Ker Ourio Salué par les critiques comme un des dignes successeurs de Toots Thielemans, Olivier Ker Ourio est non seulement un soliste très demandé (Alexandre Desplat, Sylvain Luc, Marcel Azzola, Michel Legrand, Didier Lockwood, Danyel Waro...), mais également un brillant compositeur et leader inspiré. Dans ses 11 albums enregistrés à ce jour, ses compositions dévoilent un monde poétique habité de mélodies lyriques, d'harmonies inventives et de rythmes inhabituels. Le monde d' OKO a le souffle de l'âme.À propos de Quentin DujardinCompositeur, guitariste & producteur, Quentin Dujardin crée un univers unique autour de ses guitares nylons. Sa ligne de conduite reste attachée de façon immuable au son et à l'émotion. Le guitariste a notamment collaboré internationalement live ou studio avec Toots Thielemans, Lee Townsend, Manu Katché, Bijan Chemirani, Nicolas Fiszman, Mahsa Vahdat, Richard Bona, Bert Joris, Doron David Sherwin, Didier Laloy et beaucoup d'autres. Il est également ambassadeur pour la Fondation Yehudi Menuhin.Titres interprétés au grand studio : Madagascar Live RFI voirShy Away (Feat. David Linx), extrait de l'albumBlues for M&N, Live RFILine Up : Olivier Ker Ourio, harmonica, Quentin Dujardin, guitareSon : Benoît Letirant & Mathias Taylor (+mixage)► Album Serendipity (Agua Music/ Dist. Inouïe 2024)Voir le clip Song For PacoVoir le clip En T'attendantPuis nous recevons la griotte Dafra Keita et le man machine Praktika pour la sortie de l'album Balani Factory. Le backpacker DJ et producteur français Jérôme Fouqueray aka Praktika a repris la route de l'Afrique de l'Ouest pour son 2e album « Balani Factory », disponible aujourd'hui sur le label Blanc Manioc. Comme fil rouge de ce nouvel album, l'artiste a choisi un instrument qui a traversé les siècles : le balafon. Après des recherches autour de cet instrument ancestral, Praktika a entrepris l'écriture de ce 2e album en s'entourant d'icône de la scène afro électronique comme le grand balafoniste malien Lansiné Kouyaté, et Sly A 10, ancien batteur de Tiken Jah Fakoly et grand percussionniste de Côte d'Ivoire.Au cours de ses recherches, Praktika découvre l'existence de Zélé de Papara, chanteuse ivoirienne des années 90 méconnue du grand public, dont la voix et l'histoire singulière éveillent sa curiosité. Il propose alors à la chanteuse Jahelle ainsi qu'à la rare griotte burkinabé Dafra Keita de poser chacune leur voix sur le morceau en hommage à la chanteuse Zélé de Papara, la cantatrice sénoufo.Titres interprétés au grand studio : Dafra (Feat. Dafra Keita) Live RFIBalany Factory, extrait de l'albumZélé (Feat. Jahelle) Live RFILine Up : Dafra Keita, chanteuse, balafon et chant, Praktika, machinesSon : Jérémie Besset, Mathias Taylor (+mixage)► Album Balani Factory (Blanc Manioc 2024) - Voir le clip Dr BalafonConcerts 27 avril au 4 mai 2024 – Djéguélé Festival (festival du balafon), Bondoukou le 27 avril et Boundiali le 3 mai (Côte d'Ivoire).

The Jeff & The Jer recorded a full episode with Lee Townsend on Wednesday. The first half dealt with the recent allegations that Phil Imbrogno forged his education credentials. Anything we had to say was purely speculative because Phil's public response has been to leave the paranormal field and go silent. That's publicly. But a funny thing happened on the way to Thursday: Phil personally emailed Jeremy his side of the story out of the blue and so the first half of the show had to be scrapped as irrelevant in light of new information--information Jer still cannot really share with the audience, but can talk around. And that's only the beginning of the problems they faced with this week's episode. In fact, the way they ended with Lee was bizarre and the way Jeff & Jer ended their afterchat on Thursday was impossibly weird. Is there a ghost in the machine? Imbroglios indeed! Thankfully, what was salvaged and cobbled together is seamless enough and full of the Paratopia mind food we all crave. (originally aired 07.07.2011)

On today's episode of the G Word, our guests will be discussing the CanGene-CanVar programme. Funded by Cancer Research UK, the 5-year programme aims to create an interface between NHS clinical care and research that will expand genetic testing access for those with inherited cancers. Our host Amanda Pichini, Clinical Lead for Genetic Counselling at Genomics England, is joined by Dr Helen Hanson, Consultant in cancer genetics at the Peninsular Regional Genetic Service, Kelly Kohut, Lead Genetic Counsellor at the South West Thames Centre for Genomics, and Rochelle Gold, Patient Representative on the CanGene-Canvar research programme and co-founder of BRCA Journey.   "There is also the possibility of finding out genetic information that's familial or inherited, which could mean that the information is not only important for the person who is being treated for cancer at the current time but also as a next step informing relatives that they might have a higher chance of getting cancers in the future due to a genetic variant..."     You can read the transcript below or download it here: How-are-genetic-tests-transforming-cancer-prevention.docx   Amanda: Hello and welcome to The G Word.  My name is Amanda Pichini and I'm the Clinical Lead for Genetic Counselling at Genomics England.  We know that cancer is a very common disease.  About one in two people will develop cancer at some point in their lifetime.  Cancer is a disease of the genome involving many changes to a person's genome over time as well as other factors.  Only a small proportion of all cancers are inherited, but this can have a significant impact for those families who have a much higher risk of cancer and options to reduce their risk.    Today I'm delighted to be joined by Dr Helen Hanson, Consultant Clinical Geneticist; Kelly Kohut, Consultant Genetic Counsellor; and Rochelle Gold, Patient Representative and co-founder of BRCA Journey.  We'll be discussing the CanGene-CanVar programme which aims to link NHS clinical care and research to expand access to genetic testing and care for people with inherited cancers.  Welcome, Rochelle, Helen and Kelly to The G Word.  Thank you for joining me today.  Let's start with some introductions.  Rochelle, over to you?  Rochelle: Hi, everyone.  I'm Rochelle and I'm one of the Patient Reps on the CanGene-CanVar research programme.  I also co-founded an organisation called BRCA Journey that helps to raise awareness of the BRCA genetic mutation amongst both clinicians and the community, and also supports people who might be at risk of the mutation or who are thinking about testing, all the way through to maybe having preventative treatment or preventative surgery.  We support those with that decisions.  We're not genetic counsellors but we do basically talk to people about our experience and knowledge that we have of what it's like as a patient to be someone living with the mutation.    Amanda: Thank you.  Could you briefly tell us what BRCA is and how you came to be a patient?  Rochelle: BRCA is a genetic mutation that puts people at greater risk of breast and ovarian cancer.  My mum had the mutation, in fact she had two of the mutations which is apparently quite rare.  She passed away from breast cancer and just before she passed away I found out that I had the genetic mutation as well.  I personally have had preventative surgery and reconstruction to prevent myself from getting breast and ovarian cancer.  I got involved in being a patient rep so that I can advocate for people who may have the mutation, but also make sure that as many people as possible can be tested and be aware that they have the mutation and have that power to have the knowledge to be able to do something about it should they so wish.  Amanda: Thank you so much for sharing that with us.  Kelly, over to you?  Kelly: Hello, everyone.  I'm Kelly Kohut, I'm the Lead Consultant Genetic Counsellor at the South West Thames Centre for Genomics, which is based at St George's Hospital in London.  For many years I've been working in clinical practice in genetic counselling, seeing patients and their families regarding personal or family history of cancer, offering genetic testing where that's available, and then giving the results and helping to refer people on for surveillance programmes and to discuss risk reducing options, and also help a lot with communication within families, sharing the information from the genetic test results.    For the past few years, I've also been doing my own research as part of the CanGene-CanVar programme, funded by the charity Cancer Research UK.  This has involved partnering directly with patients and other expert stakeholders to co-design a patient website to support decision-making around the genetic chances of getting cancer in families.     Amanda: Thank you.  And Helen?  Helen: Hi, everyone.  I'm Helen Hanson, I'm a Consultant in Cancer Genetics.  I'm based at the Peninsular Regional Genetic Service which is in Exeter.  In my clinical practice I see patients who either have a cancer diagnosis to consider whether they may have an inherited susceptibility or people who maybe have a family history of cancer to try and determine if they are at risk due to their family history.  Like Kelly and Rochelle I've also been involved in the CanGene-CanVar programme for the last four years.  I've been involved in work package three of the programme which is developing clinical guidelines with the patients who have an inherited predisposition to cancer.  I was also fortunate enough to be given some funding to carry on with this work beyond the programme in the new NIHR Exeter Biomedical Research Centre.    Also, I'm currently chair of the UK Cancer Genetics Group, who has an aim of improving the management of patients who have an inherited predisposition to cancer.  It's been really great to work on all these different things and try and bring things together to try and improve care for patients who do have rare inherited genetic conditions predisposing to cancer.   Amanda: Fantastic.  Thanks, everyone.  Kelly, I wondered if you could start us off by just explaining a little bit more about how genetics and genomics is relevant to cancer.  Especially inherited cancers, why is this an important thing to talk about?  Kelly: The availability of genetic testing has been increasing steadily over the years.  Currently from pretty much anyone who's been diagnosed with cancer there should be some awareness around the possible benefit of knowing the genetics behind the development of that cancer and whether any genetic or genomic testing might help to choose more personalised treatments or surgical options for that cancer that's been diagnosed.  There is also the possibility of finding out genetic information that's familial or inherited, which could mean that the information is not only important for the person who is being treated for cancer at the current time but also as a next step informing relatives that they might have a higher chance of getting cancers in the future due to a genetic variant and that they could ask their GP for referral to genetics to be offered genetic testing and to find out about their chances of getting cancer and the choices for how to manage that.    Amanda: Thank you.  There are clearly some important things that someone would do differently when they know they have an inherited cancer.  Helen, how can we make sure that clinicians and patients and families know what do to in these situations?  Helen: Following on from Kelly explaining the amount of genetic testing we can offer has really increased over the last five to ten years and we're not in a position to offer many more patients genetic testing, it's important that we also consider what to do with that information when we discover somebody does have a pathogenic variant or a mutation in a cancer predisposition gene.  There are over 100 different cancer predisposition genes described and actually having a variant in one these genes is rare.  It's difficult and like other conditions in medicine due to their rarity to really understand how best to manage these patients.  But what's very important is that we try to understand how best we can help patients manage their cancer risk based on the lifetime risk of cancer and the particular cancers that they can develop and ensure that patients across the country are all being given the same advice, the same information about their cancer risks.    Through the CanGene-CanVar programme we've had a whole work package which is devoted to clinical guideline development where we've looked at a number of these genes and looked at the evidence that is available in terms of cancer risks, the utility of surveillance or early detection of cancers in that condition, and also whether risk-reducing surgery could be offered.  Really try to bring together groups of experts to discuss the evidence because for some genes it really is quite limited due to the rarity of the condition.  The overarching aim is really to develop guidance that is relevant and can be offered in our current clinical practice and is consistent to all patients who have a variant in one of these genes.  Amanda: You mentioned that many of these inherited cancer conditions are very rare. Is there a need to look internationally or collaborate internationally?  How do you pull some of these things together when there's so little information?    Helen: We definitely have found it really helpful to have international collaborations.  Some of these conditions there may be very few patients in the UK who have this condition, so each individual clinician who works in cancer genetics may have only seen one or two patients with the condition than themselves and, therefore, collaborating with international colleagues has been very helpful and we have recently published some guidance for a condition BAP1 tumour predisposition syndrome which increases an individual's lifetime risk of developing mesothelioma, which is a type of lung cancer, renal cancer and melanomas of the skin and eye.  This is a rare condition, but we worked with European colleagues to develop a set of guidelines advising what surveillance the patient should have, so looking to melanomas, looking for early detection of kidney cancers, so having that international collaboration has been really very helpful because in the UK there are so few cases per centre of individuals who have that condition.     Amanda: That sounds really helpful.  Rochelle, we know that shared decision-making is so important in healthcare.  How can we make sure that the voices of patients are reflected within these guidelines that were developing and that it's clear to them what needs to happen for their healthcare?     Rochelle: I think it's really important that patients are involved in the development of the guidelines, first of all, and actually within those guidelines there is stuff that talks about that, being about shared decision-making.  A lot of these guidelines are in a language that are quite a clinical language that is not necessarily accessible to patients themselves.  It's really important that they're part of the creation of them but also that there are things out there that enable people to understand what are these guidelines about, what do these guidelines actually mean in practice.  When you find out that you have a particular genetic mutation, of course, the first place you probably go is Google.  You find a hell of a lot of information and you find all sorts from different countries and different people and different organisations.  You're like which is the thing I need to look at, which is the thing that actually tells me what's going on, which is the thing that really helps me to understand what this actually means for me and what should happen to me?  What is the pathway for me, etc.    I think we also need to recognise that people have different levels of health literacy as well.  I am someone who can probably navigate my way around a very complex system, which is the NHS, maybe better than other people.  But there are plenty of people out there who this is new people, this is a completely new thing that's happened to them, a completely new thing to understand.  If you're not used to being part of health systems and navigating your way around it, it can be quite scary.  What does mutation mean?  What does it mean for me?  What does it mean to my future?  What does it mean for my family?  All this information.  There needs to be something somewhere that talks about this, some sort of lay way and helps people to understand what this means for them and helps them to engage with it.  To some extent, that's where my organisation was born from, that thing about having somebody who can just talk about it in normal words, in normal terms and normal views of what these guidelines actually do mean.  The fact is they are just guidelines, they don't tell you this is what you do.  You're this person, you're in this circumstance, you do this, it doesn't.  There's some ambiguity there that needs to be navigated by the patient and they need support in order to do that.  Amanda: That's a great point.  Having previously worked as a genetic counsellor, also seeing patients with inherited cancer conditions, it really strikes you how individual each person's journey and decisions are.  They're thinking about all kinds of factors in their life or in their family's life.  Navigating through that and understanding do I have surgery or do I have screening and how do I make decisions about this is based on my previous experiences and so many other factors.  Having access to different sources of support to help people navigate through that feels incredibly important.    We've been talking a bit about inherited cancers in general, but you're all here because you're involved in the CanGene-CanVar programme.  Kelly, could you tell us a bit more about what that is and what he programme is aiming to achieve?  Kelly: The CanGene-CanVar programme is a five year grant funded by Cancer Research UK.  It involves six different work packages, so lots of experts all around the UK have been allowed to have some dedicated time to work on specific areas where there hasn't been enough resource put in in the past which has resulted in a real gap between the research and the current findings and actually using that information to benefit patients by bridging the gap and putting those research findings into clinical care.    My programme is in work package four which is co-designing patient resources which are decision support interventions.  Basically, it's a website and it can be printed as a booklet and it's interactive and it's up to date and it's personalised to help convey the complicated information about genetic cancer conditions in a way that's meaningful and patients can understand, and it helps them with their personalised shared decision-making.  The CanGene-CanVar programme is underpinned by the patient reference panel and they've been involved, including Rochelle and others, from the conception of the idea of the programme and all the way through with various different activities helping to look at documents as they're developed, before their finalised, and giving input in focus groups and one-on-one and email conversations.  They're called upon frequently to share their lived experience and say what's important to them when they make decisions and that's really helped to drive the direction of the research and inform the results before they're published.     Amanda: That sounds like a really helpful approach to developing something in a way that's really working very closely with patients and participants.  Rochelle, it sounded like you were involved in that.  Can you tell us a bit about what that was like from your perspective?  Rochelle: It's really rewarding, it's really motivating to be actually one of the patient reps in relation to this.  I don't want to make my colleagues from the team blush, but it's just such an inclusive environment where as a patient is really welcomed, really heard, it's very much a partnership and that's been really, really important and it makes you feel valued as a patient and actually the importance of the lived experience the patient view has really been prominent in this.  I would say that's why it's helped develop such a useful tool, the fact as a patient people are really valuing and taking into account our lived experience, our views, our understanding.  It's been quite fun in some of the sessions.  There have been some good debates between us and some of the clinicians and it's been really good and really useful.  I think some of the people who maybe haven't encountered a patient panel before and engaged with patient's lived experience have probably learn a lot from it because we are pretty empowered to use our voice in this.  It's been a really great experience.   Amanda: I'd love to dig into those debates a bit more.  Kelly, were there things that you changed in the decision aid as a result of some of those discussions or as a result of that input that maybe surprised you?   Kelly: We have made changes based directly on what we've learned from the patients presenting their lived experiences.  They've been very open and honest with us.  Like Rochelle, I felt so privileged to be part of this real partnership with the patients.  As a genetic counsellor who had many years of experience in clinical practice before moving into this research role, I've been really surprised but also gratified by how much I've been able to learn from the patients in a different way because I am sort of taking a step back, I'm there as a researcher and not directly as a clinician looking after someone one-on-one in clinic and just thinking about their specific needs at that time.  But because I'm hearing from people from all different situations, different parts of the UK and other countries and maybe it's 10/20 years since they had their genetic diagnosis are actually getting a bigger picture of their care needs that we might not have heard about as the clinicians on the ground because they might not be coming back to tell us.  If we haven't opened the door to that conversation about their personal situation or who's influencing them or what's important to them when they make decisions, we just might not have learned about the thing they're grappling with and they've gone off and maybe Googled, they've found a patient support group or something else to support them.    In my research and in my interviews and the focus groups, all of the activities I've been learning about the gaps in care, what might be needed to address that.  The decision aid has not been yet ruled into clinical practice but we're very keen to get it out there and everyone wants it and wants to use it.  We want to make sure that we've developed it in a robust patient-centred way as much as we can for us before we put it out.  It will always be updated and go through refinements, but hopefully in the New Year we will be able to let people start using it in the real world situation.  Amanda: That's great, I'm sure you're looking forward to that.  Helen: I was just going to add to that in terms of the guideline development we've had a number of consensus meetings where we've made decisions about guidelines, for example, genes that can be predisposed to ovarian cancer and we've included patients from the patient reference panel and from other patient groups in those consensus meetings.  Again, as Kelly said, that's been so helpful because it's really brought something to those discussions and it is a different perspective than when we see patients in clinic because often we're seeing them at the point of genetic testing or maybe for their results, but actually that doesn't give us that overview of the whole patient journey and the whole patient experience.  I think that has been really one of the benefits of this programme and Kelly has been really pioneering the co-design of patient information leaflets, decision aids with patients.  Rather than clinicians designing things for patients that we think that they will understand, it's actually working with patients from the start to get things right the first time.  It's been a really great part of this programme.  Amanda: Rochelle, did you want to add something further here?   Rochelle: Yes.  I think one of the sessions that we had as a patient and clinician and researcher session that really stood out for me was when we started looking at how do people make decisions. We had academics and researchers who've looked at how do people make decisions, talk about the knowledge base and the research base that we have about it.  As a larger group of patients we got together to discuss about how have we made decisions.  It was really interesting because I don't think I've ever reflected on how I made the decision and what came from that in terms of what I did about having my mutation.  Hearing about how other people did as well, that session really does stick in my mind and actually I learnt a lot as a person about decision-making theory but also about myself and reflecting on how I make decisions.  So as a patient involved in this, it's not always about what I bring to this but actually as a patient rep you get a lot from it, too.  I've learnt a lot from the colleagues that I've worked with.  Amanda: That's fantastic.  It's really great to hear the careful thought that's gone into this, a real excellent example that hopefully others can look to.  I think, Kelly, hasn't your work won an award recently as well?  Kelly: We as a whole team won an award from the academic health science network and the NHS Confederation, it's called the Innovate Awards 2023.  This was for excellence in patient and public involvement in transformation and innovation.  Yes, it was a chance to showcase the really positive experience that we've had.  I think on all sides we've learnt a lot from each other and just to hope to inspire other researchers and clinicians to take this co-design approach with patients because we all benefit from it so much.  We think that the resources, the guidelines, everything that we develop will be better from the start if we work together throughout the project.    We're really hoping to encourage others to consider from the beginning of their idea about a research programme or clinical development to bring the patients in right at the start, because they can really help to guide where things go next and then throughout.  Even through to publications being on, committees, being co-chairs, presenting together at conferences, that can all help to really share the experience and the benefits that we get from the partnership.  Amanda: That's great, congratulations.  Coming back now to some of the aims of CanGene-CanVar and trying to bridge that gap, as you said, between research and clinical care, I guess that means there are some needs that still aren't being met that are falling through that gap at the moment.  Helen, from your perspective what are some of those unmet needs that we currently have or areas that are still needing improvement?    Helen: I think there's still lots that we have to learn, particularly about individual risks for patients.  We might have patients who all have a pathogenic variant in a certain gene but their risks might be slightly different due to factors that can modify their risk.  Trying to understand some of those risks better so that we can really have much better informed discussions with patients about their lifetime cancer risks I think would be really helpful.  Work package one of the programme is really focussing on that and looking at some of the information we have through national registries and trying to understand risks for specific genes better, which will help our discussions with patients, and then we still need to understand, which is more outside the programme, more how surveillance, so early cancer detection through screenings such as mammograms or ultrasounds for different cancers can help detect cancers early. There's still lots of information that we need to learn.    I think Kelly's decision aid which has been focussed on Lynch Syndrome, I think that can be translated across lots of other genetic conditions, because for each gene there is a different set of decisions.  For some of the genes that we developed clinical guidelines for we might be recommending slightly different management or for some of the genes we've recommended maybe a minimum and an extended level of surveillance, particularly for a gene called DICER1 where we've offered different options in childhood.  Decision aids would potentially help in some of those other genes building on the work that's already been developed as part of the programme.  Although the programme is coming to an end in the next year, I think there's still lots of work to be done in this area.   Amanda: It really sounds like you've all been collectively improving how much this work is worthwhile, so that's great to hear.  Rochelle, how about for you, are there areas that you would see as unmet needs or areas where we or research can improve to help patients and families with inherited cancers.  Rochelle: Similar to some of the stuff that Helen was saying, knowing more about what happens when people have different types of treatment, different types of surveillance and monitoring and stuff like that, I think there are things that are evolving all the time.  I think in the end when you think about gaps, there's nothing that's going to be written down on paper that says if you have this, do this.  In the end, every single patient is an individual with individual circumstances.  I think until we actually know that if you do this, this happens and this happens, this is going to be your chances of survival if you go through this route.  Even then when you've got the chance of survival, that's literally just a probability, it's not a binary this will happen or that will happen.  There's always going to be a need for discussion, there's always going to be a need for these brilliant genetic counsellors that we have to talk us through some of those complex decisions that we have to make.  I think, yes, we'll get more information, we'll get more evidence, we'll get more understanding of treatments that work best for different people, and we'll get it out there and we absolutely do need to do that.    Even when you have all the information you need, even if you made a solid decision, I mean, when I found out I had the mutation immediately I was like, right, that's it, I'll have preventative surgery after what happened to my mum.  It was an absolute no-brainer for me.  For other people it might not have been if they were at a different life stage.  I'd had my kids, I didn't need my ovaries, I didn't need my womb, it was pretty clear cut.  Even then when I was thinking about the different treatment and when to have that surgery, I got most of my information from bumping into somebody in the ladies' toilets who has been through it before.  I think there's always going to be a need in terms of being able to have those conversations to take in all the information you do that and make some sort of informed decision.  What came out of that decision-making workshop and all the other things that we did about probabilities, it's all just a model.  It's a model of what might happen.  The thing is, all of these models, they're all wrong, they just help you maybe make a discussion or a decision that might be right.  You just never know.  I still don't know if the decisions I made were the right decisions either.  There needs to be that space for people to consider their options, you're never going to get the definitive answer.    Amanda: An important message there.  We talk a lot about using digital tools to be able to do things better at scale, better ways to give information, but I think what you're saying is we can't replace certain elements of human connection, we can't underestimate the value of that.  You made a really good point earlier as well about how so many of these decisions have uncertainty and it can be really difficult to navigate the complexities of a health system.  Perhaps even more challenging if you have struggles with health literacy or if you are an underserved group in some way or another.     Kelly, I think you mentioned that some of your research has also touched on developing information for underserved groups.  Can you tell us a bit more about that?  Kelly: We recognised that there are many underserved groups that are not represented in research, in literature, and applied for additional funding to do some specific targeted projects in the community.  There were a couple of examples I can mention.  One was inspired by colleagues at the Royal Marsden who made some videos about prostate screening and the had black men and their family members talking about this in a relaxed barber's shop setting.  Through reaching out into the community I was connected with Lee Townsend from Macmillan who's been making these barbershop videos around London for the last seven years.  He's focussed on a number of topics like mental health, vaccination and cancer.  We connected and it was really about making that connection in the community, him as a trusted leader, and having formed partnerships with some of the barbers who opened up their barbershops for filming these sessions and went way beyond that.    One of them has actually trained as a counsellor himself because he said men are coming for a haircut and actually they have a bald head, they don't need the haircut, they're coming actually for the chat.  Because it's benefitting their mental health and they felt able to open up about topics that they wouldn't talk about even at home with their family members or with their friends, such as symptoms of cancer, going for cancer screening or presenting for treatment if they were symptomatic.  It's really powerful.  We've actually filmed six videos with black and minority ethnicity patients, talking about their cancer experience and they've really both helped others by setting an example that it's okay to talk about these things.  Also, through the process an added benefit was helping themselves, so it was peer support.  When they came to the barbershop to film their stories, they didn't need to stay for the whole time but they did stay for the three hours.  They said afterwards how helpful it was just to hear others in a similar situation sharing their stories.  One of them told me he's got up on stage and shared his cancer journey and he's been going to these patient groups and talking when he didn't feel able to do that in the past.  It's been a great project and we're going to be adding the videos to the CanGene-CanVar patient decision aid website soon.  Another thing that we've done in the diet and lifestyle section of the website where it talks about things that people might do to lower their chances of getting cancer have partnered with Professor Ranjit Manchanda who had some colleagues in India and made some infographics that specifically depict patients of a South Asian heritage and the types of foods that they might be choosing to give examples of how they might for example try to get more fibre in their diet to lower the chances of getting bowel cancer or trying to eat more fruits and vegetables or drink less alcohol.  It shows images of Indian patients.  What people have told me in my research, my interviews, focus groups, is they tend to go and try to search for something that means something to them, so they're looking for someone like me.  One of the patients I filmed she said that she had breast cancer as a young black woman and she was only middle-aged women on the websites.  She thought why is this, do black women not get breast cancer or young women like me?  For her to share her story was very brave but also has the potential to help a lot of other people in the community.   Amanda: That's really powerful, so understanding those nuances in different cultures or communities or groups is just so crucial to really being able to also develop information or messages or provide care that's going to really reach those people where they are, I guess.  This has been a really fantastic conversation.  If we could end with a final question, it would be great to hear from your perspective just one thing that you'd like to see in the next five to ten years when it comes to care for inherited cancer susceptibility conditions.  Helen, let's start with you?  Helen: I think that in developing the guidelines one of the things that we've had to struggle or grapple with is a lack of evidence and the lack of the data that's available for some of these conditions.  I'm really hoping that over the next five to ten years that we will see much more data on cancer risks and outcomes of surveillance progress for people who have an inherited predisposition.  Then we can utilise that information to be able to share with patients to enable them to make best decisions about their care.  There's a number of initiatives that are currently underway thinking about how we might better collect data on patients with inherited cancer predisposition in the UK, through registries, so I am really hoping that we manage to get some useful data that we can then use in our discussions with patients going forward.  Amanda: Thank you.  Kelly?  Kelly: I think that over the next five to ten years as awareness and availability of genetic testing continues to increase, we know that there will be more and more families identified who have a higher genetic risk of getting certain cancers.  We can't replace that personalised counselling that takes place, face-to-face or sometimes telephone and video appointments with a healthcare profession.  So there are more resources needed for the NHS to deliver this.  To compliment that, the patient website decision aid that we have co-designed is one way to help.  What patients tell us they would like, access to a central trusted source of information that's up to date.  Importantly in genetics it's very fastmoving, there's a lot of research, guidelines are changing, and it's very crucial to have information that's correct and relevant for people, and also meaningful.  We can only do that by partnering together with patients and co-designing things rather than designing them and asking them afterwards if they're useful.  It's a partnership all the way through that we all benefit from.    As I said earlier, it's not a one-size-fits-all, decision-making is so personal and shared decision-making is recommended but we don't always have enough time in clinic to really address all of the issues that the patient might not have even thought about themselves.  Having something like a patient-facing resource website booklet that they can look at in their own time, prepare for their questions that they really want to focus on in clinic, it might help give them the confidence to bring something up that they might not have otherwise.  It's about a number of different ways of helping to support people.  We've identified that there are gaps in care that we could try to help address if we have more resource in future.  Those are my aspirations.  Thank you, Amanda.   Amanda: Thank you.  And Rochelle, to you?  Rochelle: I think for me I would like to have as many people as possible to understand or know about their genetic mutation status.  We know people don't even know about the fact that they may have a genetic mutation that may make them more susceptible to cancers, and we know that even then if you do can you get access to testing to know whether you've got it or not.  That is the most important thing.  My mum, if she'd known that some of this was related, if she'd had that awareness that breast and ovarian cancer in your family was related to potential genetic risk, maybe she would have pushed harder to get testing and maybe she wouldn't have been tested when it's too late.  In the end, all this knowledge and empowering people with knowledge, whether that be about empowering people with the knowledge that they may have a genetic mutation, there's a possibility of the genetic mutation, that these things are related and empowering people through the knowledge of knowing their genetic mutation status, all that is something that saves lives.  From my view, it undoubtedly probably has saved my life and so my hope for the future is that we can empower more people like me and we can save more lives.   Amanda: Thank you for our guests today Dr Helen Hansen, Rochelle Gold and Kelly Kohut.  If you enjoyed today's episode, we'd love your support.  Please subscribe to The G Word on your favourite podcast app and like, share and rate us wherever you listen.  I've been your host, Amanda Pichini.  This podcast was edited by Mark Kendrick at Ventoux Digital and produced by Naimah Callachand.  Thanks for listening.     

Legendary author and experiencer, Whitley Strieber, joins Jeff, Jer, and guest co-host Lee Townsend to discuss the new edition of 'his book, The Key. A riveting read, The Key contains perhaps the most important conversation about reality and the human future ever had. We still don't know who the mysterious man who barged into Strieber's hotel room back in 1998, whom Whitley calls, "The Master of The Key," is. But in this episode, we do learn a lot more about Strieber, a multi-dimensional man in his own right. (originally aired: 05.12.2011)

Use this link to find us on Whatnot and get £10/$10 of credit to spend! https://www.whatnot.com/invite/blankcoverpodcast  Join us on Patreon: https://www.patreon.com/blankcoverpodcast It's New Comic Book Day! Welcome to the second episode of our new sister show. Being released every Wednesday - New Comic Book Day - BCV Dom talks you through the hottest releases of the week. Plus we put a spotlight on something comic-book-y; this week's it's the brilliant Lee Townsend Enjoy! See more from us: https://linktr.ee/blankcover Get in touch with us: via twitter @PodcastCover email blankcoverpodcast@gmail.com

Picking up where we left off in the Deb Kauble Uncensored episode afterchat, Lee Townsend talks about facing his fears in the dark.  

Deb Kauble, better known by her pseudonym, Kathie Davis, in Budd Hopkins's book, Intruders, was the first woman to ever claim aliens stole her unborn baby. The problem is, she never said that. In arguably our most important episode since Emma Woods, Deb pulls no punches setting the record straight. This leads to a fantastic after chat with special guest host, Lee Townsend.

Jeff Ritzmann interviews his old research partner, whom we have heard so much about, Lee Townsend. This is an absolutely fascinating conversation and confirmation of some of the shared experiences Jeff has talked about involving Lee. More than that, it's a conversation about Whitley Strieber's proposition that alien abduction phenomena might be what the face of evolution looks like to us. Lee is that rare breed of person who gets it. Not only that, he articulates the depth of Mystery so well that this is another cannot-miss episode!

dc Talk guitarist, Relient K producer and legend of the Christian music scene for the last 30 years, Mark Lee Townsend joins the podcast to discuss 'Deathbed'. He breaks down the making of RK's most ambitious song, how Jon Foreman of Switchfoot got involved and his emotional response to the song when playing it live. Plus of course Aiden peppered him with questions of dc Talk and RK rumors and reunions.To get in touch with host Aiden Grant, email aideng@hotmail.com or https://www.instagram.com/aiden_s_grant/?hl=en Hosted on Acast. See acast.com/privacy for more information.

Guitarist for DC Talk, producer of Reliant K and musical director of The Jay Sekulow Band.  Mark and I worked together many years ago when he was the lead guitarist for "Bash-n-the-Code" and I was in the role as producer.  In part 1 we discuss his time in the band DC talk and his work with Jay Sekulow.

Guitarist for DC Talk, producer of Reliant K and musical director of The Jay Sekulow Band.  Mark and I worked together many years ago when he was the lead guitarist for "Bash-n-the-Code" and I was in the role as producer.  In part 2 we discuss his production work with Reliant K as well as his solo album, "1919: The Ballad of Rexford," written about his father.

Non-Marvel/DC September 2022 Solicits Comic Reviews: DC: Aquaman and Flash: Voidsong 1 by Jackson Lanzing, Collin Kelly, Vasco Georgiev, Rain Beredo Black Adam 1 by Christopher Priest, Rafa Sandoval, Matt Herms Dark Crisis: Young Justice 1 by Meghan Fitzmartin, Laura Braga, Luis Guerrero Flash 783 by Jeremy Adams, Amancay Nahuelpan, Jeromy Cox Earth Prime 6: Hero's Twilight Milestones in History by Reginald Hudlin, Steven Barnes, Amy Chu, Melody Cooper, Leon Chills, Alice Randall, Toure, Tananarive Due, Pat Charles, Kathryn Parsons, Francesco Francavilla, Jamal Igle, Ray-Anthony Height, Denys Cowan, Eric Battle, Don Hudson, Ron Wilson, Arvell Jones, Maria Laura Sanapo, Domo Stanton, Jahnoy Lindsay, John Stanisci, Jose Marzan Jr, Mike Gustovich, Chris Sotomayor, Michael Atiyeh, Emilio Lopez, Hi-Fi, Dan Brown, Eva De La Cruz, Andrew Dolhouse Superman's Pal Jimmy Olsen's Boss Perry White by Matt Fraction, Steve Lieber, et al Marvel: Marvel's Voices Pride 2022 by Mike O'Sullivan, Stuart Vandal, Rob London, Andrew Wheeler, Daron Jensen, Alyssa Wong, Patrick Duke, Chris McCarver, Christopher Cantwell, Danny Lore, Luc Kersten, Grace Freud, Ira Madison III, Alex Philips, Charle Jane Anders, Ted Brandt, Kei Zama, Lucas Werneck, Brittney Williams, Ro Stein, Scott Henderson, Lorenzo Susi, Stephen Byrne, Lee Townsend, Rachelle Rosenberg, Rico Renzi, Jose Villarrubia, Michael Wiggam, Tamra Bonvillain, Brittany Peer Miles Morales and Moon Girl 1 by Mohale Mashigo, Ig Guara, Rachelle Rosenberg New Fantastic Four 1 by Peter David, Alan Robinson, Mike Spicer Punisher War Journal: Blitz by Torunn Gronbekk, Lan Medina, Antonio Fabela Who is Jane Foster Thor Infinity Comic by Torunn Gronbekk, Leonard Kirk, Matt Milla Marvel Meow 9 by Nao Fuji Image: Beware the Eye of Odin 1 by Doug Wagner, Tim Odland Clementine GN by Tillie Walden, Cliff Rathburn  Silver Coin 11 by James Tynion IV, Michael Walsh Dark Horse: Lonesome Hunters 1 by Tyler Crook Ahoy: Wrong Earth: Confidence Men 1 by Mark Waid, Leonard Kirk Dynamite: Samurai Sonja 1 by Jordan Clark, Pasquale Qualano OGNs: Runaways Diary by Emily Raymond, Valeria Wicker, James Patterson Creepy Cat vol 3 by Cotton Valent Additional Reviews: Obi-Wan ep6, Ms. Marvel ep3, Kevin Can F*** Himself s1, Star Trek: Prodigy s1, Spiderhead, Absolute Fourth World vol 1, Trevor: The Musical, Bone Orchard Mythos Passageway, Centaurworld   A new feature announced!   News: Kraven movie plot, Conan license to Titan, Omninews, Miracleman Silver Age, Riverdale spinoff featuring Jake Chang, Scout kickstarts Stabbity Bunny, new OGN series from Molly Knox Ostertag   Trailers: Stranger Things s4.2   Comics Countdown: Batman: The Knight 6 by Chip Zdarsky, Carmine Di Giandomenico, Ivan Plascencia Deadly Class 53 by Rick Remender, Wes Craig, Lee Loughridge Newburn 8 by Chip Zdarsky, Jacob Phillips , Casey Gilly, Soo Lee Nocterra 11 by Scott Snyder, Tony Daniel, Marcelo Maiolo Nightwing 93 by Tom Taylor, Bruno Redondo, Wade Von Grawbadger, Adriano Lucas Lonesome Hunters 1 by Tyler Crook Something is Killing the Children 24 by James Tynion IV, Werther Dell'Edera, Miquel Muerto I Hate This Place 2 by Kyle Starks, Artyom Topilin, Lee Loughridge Beware the Eye of Odin 1 by Doug Wagner, Tim Odland Flash 783 by Jeremy Adams, Amancay Nahuelpan, Jeromy Cox

We had the pleasure of interviewing Crack The Sky over Zoom video! Fresh off the release of Crack The Sky’s latest album, TRIBES, singer/multi-instrumentalist JOHN PALUMBO is venturing out into the funky world of HOLLYWOOD BLVD, his fifth solo album due out May 21 via Carry On Music. Pre-orders are now available here. A lyric video for the title track premiered on Ventsmagazine.com yesterday, and can now be streamed on the label’s YouTube page here, which depicts the crazy and colorful town PALUMBO sings about. An artist at the top of his game, JOHN PALUMBO serves up an even dozen of finely crafted and expertly recorded gems on HOLLYWOOD BLVD. He plays all the instruments on the album himself, sans a number of key acoustic and electric slide guitar contributions from his Crack The Sky bandmate, Bobby Hird. Produced and created at PALUMBO’s home studio, HOLLYWOOD BLVD was mastered by longtime CTS associate R. Lee Townsend at Real Time Studios. The earwig-inducing sonic avenues and cleverly winding wordsmithed roads that comprise HOLLYWOOD BLVD continue to cement PALUMBO’s status as a shrewdly observational songwriter in the vein of Leonard Cohen and Lou Reed. As JOHN PALUMBO explains about the new music, “The best songs come out on the first try. ‘Hollywood Blvd,’ for example, I threw right down after establishing the groove and a proper bass line. It’s as if the song actually gave birth to itself. Songs like these usually come as a series of random thoughts put into a rhyming pattern, and they’re much more like poems than songs. Then, it’s just the task of ‘trimming the fat’ to lay in the lyric to fit the music track. Rhyming can put a bit of a crunch and a restriction on things. At the same time, you’re trying to make a point, you have to rhyme something with it. That really handcuffs me, so I’ve had to stretch the rhyming concept more than a few times.” We want to hear from you! Please email Tera@BringinitBackwards.com. www.BringinitBackwards.com #podcast #interview #bringinbackpod #foryou #foryoupage #stayhome #togetherathome #zoom #aspn #americansongwriter #americansongwriterpodcastnetwork Listen & Subscribe to BiB Follow our podcast on Instagram and Twitter! --- Support this podcast: https://anchor.fm/bringinbackpod/support

Fine Music Radio — Dr Lee Townsend, an astronomer at UCT, tells us about the merry dance going on in the universe revealing the strange and extreme physics of binary systems, where one dense neutron star sucks the living daylights out of its companion. Sometimes these binaries end up as black holes, and other strange couplings, outputting unimaginable energies when they merge, collapse, explode, and all the other violent things that can go bump in the night.

Balls and Wendi double-team tonight’s episode, as their cohort makes his way to NYC. But who better to fill the Paco-shaped hole than Baltimore comedian Rose Vineshank?? Rose joins the gang for a recap of the latest comedy nights and to talk about her recent experience performing at Roadie Joe’s. Tune in for stories of accidental home invasions, geriatric alcoholics, and more Freudian slips than you can shake a stick at. Then stick around for Rose and her razor-sharp wit in one of the most memorable hot seats of all time!   Tags: Rose Vineshank, Svedka, Roadie Joes, geriatric alcoholics, Elizabeth Taylor, E-lez-abeth Taylor, Home Invasion, DC Draft House, Blue Iguana, NPR, Diane Rehm, dating, LGBTQ, AfterEllen, Burlesque, Spaghetti, Use To Be Pete, R. Lee Townsend 

Working Class Audio #175 with Adam Muñoz!!! Adam Muñoz has been an engineer in the Bay Area since 1991. Having joined the Fantasy Studios team as a full-time House Engineer in 2008 Adam has had the opportunity to engineer sessions for many local and national recording artists. Adam has worked with artists like Herbie Hancock, Dave Mathews, Marcus Miller, Snarky Puppy, Jason Moran, Lisa Fisher, Joanna Newsom, Ambrose Akinmusire, Bruce Cockburn, Jerry Granelli, Etienne Charles, Neal Schon, Animals As Leaders, Eric Gales, Tiffany Austin, The Marcus Shelby Orchestra, Bomba Estereo, Brad Mehldau, LaToya London, Carie Rodriguez, Rupa and the April Fishes, Rinde Eckert, Autopsy, Allison Miller's Boom Tic Boom, Sean Paul, Lyle Lovett, Matt Nathanson, Six Pence None the Richer, Hank Williams III, Otis Redding and Vince Guaraldi. Adam’s long-time relationship with Bill Frisell and producer Lee Townsend resulted in the 2015 AND 2016 GRAMMY Award nomination for Best Contemporary Instrumental Album. Adam came to Fantasy after many years as an independent engineer working out of some of the finest studios in the San Francisco and abroad.  As a staff engineer at Different Fur and Brilliant Studios, Adam worked on many notable sessions for artists like Faith No More, Mr. Bungle, Fantomas, Sleep, Neurosis, Chris Isaak, Bonnie Raitt, The Cranberries, Paula Cole and on George Winston’s Grammy Award-winning project “Forest.” Adam has been fortunate to have worked along side many super talented producers and engineers including Andy Wallace, Matt Wallace, Howard Johnston, Billy Anderson, Frankie Blue, Karl Derfler, Marc Senasac, John Cuniberti, Judy Clapp, Mike Curb, Steven Haigler, Thom Wilson and more. Adam's background also includes ADR/VO, Foley, lock-to-picture sessions and orchestral film scores. Photo by Monica Jane Frisell  About this Interview: Adam joins me to talk about his journey starting out as a DJ examining the credits on the back of records to working as a house engineer at the world famous Fantasy Studios in Berkeley, California. We talk studio leadership, survival, dedication and the increasing difficulty of repeating his journey in todays recording world.  Enjoy! - Matt Show notes and links: Adam's site: http://www.adammunoz.com/ Fantasy Studios: http://fantasystudios.com/ Saul Zaentz Company: http://www.zaentz.com/

Mark Lee Townsend is known best as guitarist for the Christian rock band dc Talk. Townsend's career started as a member, singer, guitarist and songwriter for the pop and Christian band Bash 'N The Code from 1986 through 1991.

Producer Lee Townsend is my guest on the show this week. Lee is a producer in the truest sense of the word. He’s not a performing musician, never has been, but has always been deeply into music and he brings a philosophy and easy going nature to sessions that make people rally around and perform their best. Lee is best known for his decades-long relationship in the studio and as manager for Bill Frisell, with whom he has made many records, earned Grammy Awards and countless other accolades, but he has also made some amazing records for artists as diverse as Dave Holland, Viktor Krauss, John Scofield, Charlie Hunter, Louden Wainwright, Carrie Rodriguez, and many more. He is an artistic member of the group Floratone, which is an experimental collaboration with Frisell, Matt Chamberlain, Tucker Martine, and Lee. He has also worked as VP of A&R for Verve/Polygram and as General Manager of of ECM Records in the USA. I thought Lee would be a great addition to the series here as someone who brings an intense love and passion for music to the table and has a long history of great records under his belt. He is a true Music Maker and Soul Shaker!

Commercial beekeeper Lee Townsend and Canola Council of Canada agronomist Gregory Sekulic discuss bee health, neonics, the role of bees in canola production and best management practices for growers. To learn more about the sweet relationship between bees and canola visit http://www.canolacouncil.org/markets-stats/industry-overview/bees-and-canola-a-sweet-relationship/

>John Martyn-"Small Hours"-One World >Nick Drake-"One Of These Things First"-Bryter Layter >The Upsetters-"Rebel’s Hop" (Dub Version)-The Complete Lee Scratch Perry Sessions >Floratone-"Swamped"-Floratone (Bill Frisell, Matt Chamberlain, Lee Townsend, Tucker Martine) >Autechre-"Parhelic Triangle"-Confield Moodymann-"Lyk U Use 2"-Moodymann >Sly & The Family Stone-"If You Want me To Stay"-Fresh >Magazine-"Thank You (Falletinme Be MiceElf Agin)-Correct Use Of Soap […]

El guitarrista Bill Frisell y el baterista Matt Chamberlain se reúnen por segunda vez con los productores Lee Townsend y Tucker Martine en Floratone II. Con ellos colaboran Mike Elizondo (b), Jon Brion (tcl), Ron Miles (tp) y Eyvind Kang (viola). Es una de las propuestas de la edición de "Club de Jazz" del 12 de septiembre de 2012 en la que la excusa de un viaje palestino nos trae la música de Anouar Brahem ("The astounding eyes of Rita"), Robert Wyatt, Gilad Atzmon y Ros Stephen ("... for the ghosts within") y Avishai Cohen con Nitai Hershkovits ("Duende"). El "Jazz Porteño" de Alberto Varela recupera un trabajo de 1996 del guitarrista brasileño Guinga bajo el título de "Cheio de dedos". "desde mi cadiera" Jesús Moreno repasa la última edición del Festival de Uzeste y el tributo que rindieron al pianista Jef Gilson. Lo ilustra con su "Suite pour San Remo" grabada en 1966. Anxo encuentra en los "Éxitos secretos" de Ángel Petisme los "Ritmos Latinos". Y además, junto a Luis Díaz García en el "Tren Azul", le cantamos cumpleaños feliz a Sonny Rollins con música de su "Vol.2" para Blue Note de 1957, Toda la información y derechos: http://www.elclubdejazz.com

El guitarrista Bill Frisell y el baterista Matt Chamberlain se reúnen por segunda vez con los productores Lee Townsend y Tucker Martine en Floratone II. Con ellos colaboran Mike Elizondo (b), Jon Brion (tcl), Ron Miles (tp) y Eyvind Kang (viola). Es una de las propuestas de la edición de "Club de Jazz" del 12 de septiembre de 2012 en la que la excusa de un viaje palestino nos trae la música de Anouar Brahem ("The astounding eyes of Rita"), Robert Wyatt, Gilad Atzmon y Ros Stephen ("... for the ghosts within") y Avishai Cohen con Nitai Hershkovits ("Duende"). El "Jazz Porteño" de Alberto Varela recupera un trabajo de 1996 del guitarrista brasileño Guinga bajo el título de "Cheio de dedos". "desde mi cadiera" Jesús Moreno repasa la última edición del Festival de Uzeste y el tributo que rindieron al pianista Jef Gilson. Lo ilustra con su "Suite pour San Remo" grabada en 1966. Anxo encuentra en los "Éxitos secretos" de Ángel Petisme los "Ritmos Latinos". Y además, junto a Luis Díaz García en el "Tren Azul", le cantamos cumpleaños feliz a Sonny Rollins con música de su "Vol.2" para Blue Note de 1957, Toda la información y derechos: http://www.elclubdejazz.com

Josh, known as ''jayr'' on the message board, joins us to discuss a post he made about last week's ''Echoes In A Yawning Chasm'' episode that gave Jer some new insights into his nothingness/everythingness identity experience. This is another mind-bending conversation that will have you thinking in perhaps completely new ways.But first, Lee Townsend joins Jeff & Jer to investigate famed channeled entities ''Ramtha'' and ''Seth'' and talk about what makes these entity claims different from Shroud Man and even Jer's unconscious movements, which could easily be mistaken for channeling.

Jeff & Jer recorded a full episode with Lee Townsend on Wednesday. The first half dealt with the recent allegations that Phil Imbrogno forged his education credentials. Anything we had to say was purely speculative because Phil's public response has been to leave the paranormal field and go silent. That's publicly. But a funny thing happened on the way to Thursday... Phil personally emailed Jeremy his side of the story out of the blue and so the first half of the show had to be scrapped as irrelevant in light of new information--information he still cannot really share with the audience, but can talk around.And that's only the beginning of the problems they faced with this week's episode. In fact, the way they ended with Lee was bizarre and the way Jeff & Jer ended their after chat on Thursday was impossibly weird. Is there a ghost in the machine? Imbroglios indeed!Thankfully, what was salvaged and cobbled together is seamless enough and full of the Paratopia mind food we all crave.

Legendary author and experiencer Whitley Strieber joins Jeff, Jer, and guest co-host Lee Townsend to discuss the new edition of ''The Key,'' a riveting book that contains perhaps the most important conversation about reality and the human future ever had. We still don't know who The Master of The Key, as Whitley calls him, is--This mysterious man who barged into Strieber's hotel room back in 1998. But in this episode, we do learn a lot more about Strieber, a multi-dimensional man in his own right.

Deb Kauble, better known by her pseudonym Kathie Davis in Budd Hopkins INTRUDERS, was the first woman to ever claim aliens stole her unborn baby. The problem is She never said that. In arguably our most important episode since Emma Woods, Deb pulls no punches setting the record straight. This leads to a fantastic after chat with special guest host Lee Townsend.

Jeff Ritzmann interviews his old research partner we've heard so much about: Lee Townsend. This is an absolutely fascinating conversation and confirmation of some of the shared experiences Jeff has talked about involving Lee. More than that, it's a conversation about Whitley Strieber's proposition that alien abduction phenomena might be what the face of evolution looks like to us. Lee is that rare breed of person: He gets it. Not only that, he articulates the depth of Mystery well. Do not miss this one!